TY - JOUR
T1 - A multimodal intraosseous infusion of morphine and ketorolac decreases early postoperative pain and opioid consumption following total knee arthroplasty
AU - McNamara, Colin A.
AU - Laurita, Jason
AU - Lambert, Bradley S.
AU - Sullivan, Thomas C.
AU - Clyburn, Terry A.
AU - Incavo, Stephen J.
AU - Park, Kwan J.
N1 - Copyright © 2023 Elsevier B.V. All rights reserved.
PY - 2023/8
Y1 - 2023/8
N2 - Background: Multimodal pain management regimens and intraosseous infusion of morphine are two novel techniques that show promise in decreasing postoperative pain and opioid consumption following total knee arthroplasty. However, no study has analyzed the intraosseous infusion of a multimodal pain management regimen in this patient population. The purpose of our investigation was to examine the intraosseous administration of a multimodal pain regimen comprised of morphine and ketorolac during total knee arthroplasty with regard to immediate and 2-week postoperative pain, opioid pain medication intake, and nausea levels. Methods: In this prospective cohort study with comparisons to a historical control group, 24 patients were prospectively enrolled to receive an intraosseous infusion of morphine and ketorolac dosed according to age-based protocols while undergoing total knee arthroplasty. Immediate and 2-week postoperative Visual Analog Score (VAS) pain scores, opioid pain medication intake, and nausea levels were recorded and compared against a historical control group that received an intraosseous infusion of morphine alone. Results: During the first four postoperative hours, patients who received the multimodal intraosseous infusion experienced lower VAS pain scores and required less breakthrough intravenous pain medication than those patients in our historical control group. Following this immediate postoperative period, there were no additional differences between groups in terms of pain levels or opioid consumption, and there were no differences in nausea levels between groups at any time. Conclusions: Our multimodal intraosseous infusion of morphine and ketorolac dosed according to age-based protocols improved immediate postoperative pain levels and reduced opioid consumption in the immediate postoperative period for patients undergoing total knee arthroplasty.
AB - Background: Multimodal pain management regimens and intraosseous infusion of morphine are two novel techniques that show promise in decreasing postoperative pain and opioid consumption following total knee arthroplasty. However, no study has analyzed the intraosseous infusion of a multimodal pain management regimen in this patient population. The purpose of our investigation was to examine the intraosseous administration of a multimodal pain regimen comprised of morphine and ketorolac during total knee arthroplasty with regard to immediate and 2-week postoperative pain, opioid pain medication intake, and nausea levels. Methods: In this prospective cohort study with comparisons to a historical control group, 24 patients were prospectively enrolled to receive an intraosseous infusion of morphine and ketorolac dosed according to age-based protocols while undergoing total knee arthroplasty. Immediate and 2-week postoperative Visual Analog Score (VAS) pain scores, opioid pain medication intake, and nausea levels were recorded and compared against a historical control group that received an intraosseous infusion of morphine alone. Results: During the first four postoperative hours, patients who received the multimodal intraosseous infusion experienced lower VAS pain scores and required less breakthrough intravenous pain medication than those patients in our historical control group. Following this immediate postoperative period, there were no additional differences between groups in terms of pain levels or opioid consumption, and there were no differences in nausea levels between groups at any time. Conclusions: Our multimodal intraosseous infusion of morphine and ketorolac dosed according to age-based protocols improved immediate postoperative pain levels and reduced opioid consumption in the immediate postoperative period for patients undergoing total knee arthroplasty.
KW - Intraosseous medications
KW - Multimodal pain management
KW - Perioperative pain control
KW - Total knee arthroplasty
KW - Arthroplasty, Replacement, Knee/adverse effects
KW - Prospective Studies
KW - Humans
KW - Nausea/drug therapy
KW - Morphine/therapeutic use
KW - Ketorolac/therapeutic use
KW - Infusions, Intraosseous
KW - Analgesics, Opioid/therapeutic use
KW - Pain, Postoperative/drug therapy
UR - http://www.scopus.com/inward/record.url?scp=85164028857&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85164028857&partnerID=8YFLogxK
U2 - 10.1016/j.knee.2023.06.002
DO - 10.1016/j.knee.2023.06.002
M3 - Article
C2 - 37399631
AN - SCOPUS:85164028857
SN - 0968-0160
VL - 43
SP - 129
EP - 135
JO - Knee
JF - Knee
ER -